SJS Investment Consulting’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
SJS Investment Consulting's IRWD Position: Q3 2026 in Review
SJS Investment Consulting increased its Ironwood Pharmaceuticals (IRWD) stake by 345% in Q3 2026, buying an estimated $5.59K and bringing the position to 1,727 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1553.
SJS Investment Consulting first reported a position in IRWD in Q1 2022 and has held it in 13 quarters since. 50 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- SJS Investment Consulting held 1,727 shares of Ironwood Pharmaceuticals worth $6.86K as of Q3 2026.
- SJS Investment Consulting bought 1,339 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $5.59K.
- Ironwood Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1553 holding.
- SJS Investment Consulting first reported a position in Ironwood Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
- 50 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.